Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianglin Yuan

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Journal of Oncology|July 21, 2022
Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung AdenocarcinomaShuangshuang Mao, Zuhua Chen, Yingying Wu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|August 25, 2005
Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometryXiaoyan Shi, Xianglin Yuan, Deding Tao, et al.
Oncology Letters|May 12, 2020
IEO model: A novel concept describing the complete metastatic process in the liver microenvironmentLu Wang, Yinan Sun, Minxiao Yi, et al.
Frontiers in Oncology|December 17, 2020
A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric CancerZuhua Chen, Bo Liu, Minxiao Yi, et al.
Aging|November 24, 2020
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbiditiesLu Wang, Yinan Sun, Ye Yuan, et al.
Radiation Oncology (London, England)|March 14, 2025
Radiation-induced lung injury: from mechanism to prognosis and drug therapySheng Wang, Duo Xu, Lingyan Xiao, et al.
International Journal of Medical Sciences|June 16, 2025
Fructose Metabolism in Cancer: Molecular Mechanisms and Therapeutic ImplicationsXinyi Chen, Mu Yang, Lu Wang, et al.
Critical Reviews in Oncology/Hematology|April 29, 2023
The role of calcium channels in prostate cancer progression and potential as a druggable target for prostate cancer treatmentMotuma Yigezu Daba, Zhijie Fan, Qinyu Li, et al.
Frontiers in Immunology|February 16, 2024
MUC1 and MUC16: critical for immune modulation in cancer therapeuticsXinyi Chen, Ineza Karambizi Sandrine, Mu Yang, et al.
Oncology Research and Treatment|December 9, 2022
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric CancerQian Niu, Jiamin Liu, Tingting Huang, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Journal of Oncology|July 21, 2022
Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung AdenocarcinomaShuangshuang Mao, Zuhua Chen, Yingying Wu, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|August 25, 2005
Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometryXiaoyan Shi, Xianglin Yuan, Deding Tao, et al.
Oncology Letters|May 12, 2020
IEO model: A novel concept describing the complete metastatic process in the liver microenvironmentLu Wang, Yinan Sun, Minxiao Yi, et al.
Frontiers in Oncology|December 17, 2020
A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric CancerZuhua Chen, Bo Liu, Minxiao Yi, et al.
Aging|November 24, 2020
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbiditiesLu Wang, Yinan Sun, Ye Yuan, et al.
Radiation Oncology (London, England)|March 14, 2025
Radiation-induced lung injury: from mechanism to prognosis and drug therapySheng Wang, Duo Xu, Lingyan Xiao, et al.
International Journal of Medical Sciences|June 16, 2025
Fructose Metabolism in Cancer: Molecular Mechanisms and Therapeutic ImplicationsXinyi Chen, Mu Yang, Lu Wang, et al.
Critical Reviews in Oncology/Hematology|April 29, 2023
The role of calcium channels in prostate cancer progression and potential as a druggable target for prostate cancer treatmentMotuma Yigezu Daba, Zhijie Fan, Qinyu Li, et al.
Frontiers in Immunology|February 16, 2024
MUC1 and MUC16: critical for immune modulation in cancer therapeuticsXinyi Chen, Ineza Karambizi Sandrine, Mu Yang, et al.
Oncology Research and Treatment|December 9, 2022
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric CancerQian Niu, Jiamin Liu, Tingting Huang, et al.
Pageof 23